GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

ACADIA Pharmaceuticals ACAD · USD

Health Care · US listing · 🇺🇸 United States

Compare

16.50

-22.28%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

27 analysts, 1 Nov 2026. The analysts' own views, not ours.

  • 8Strong buy
  • 12Buy
  • 6Hold
  • 1Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Nov 2026. Not our view.

Last close 16.50Average target 33.29

Low
14.50
Average
33.29
Median
35.50
High
49.00

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
Revenue$1.27bn$1.43bn$1.60bn$1.72bn$1.86bn
Revenue, highest$1.30bn$1.49bn$1.79bn$1.83bn$1.99bn
Revenue, lowest$1.25bn$1.40bn$1.50bn$1.65bn$1.79bn
Earnings per share0.620.941.581.972.62
Earnings per share, highest0.851.792.952.152.85
Earnings per share, lowest0.460.480.961.882.49
Analysts141414812

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Forecast0.200.070.040.140.150.140.110.22
Reported0.310.180.021.600.420.160.11-0.02
Difference+55.6%+163.9%-50.0%+1067.9%+178.1%+14.4%-3.2%-109.1%

Rating changes

Latest broker notes

  • UBSBuy
  • NeedhamBuy
  • CitigroupBuy
  • RBC CapitalOutperform
  • OppenheimerPerform
  • CitizensMarket Outperform
  • StifelHold
  • BMO CapitalOutperform
  • RBC CapitalOutperform
  • B of A SecuritiesBuy
  • CitigroupBuy
  • Canaccord GenuityBuy

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

4 / 10

Revenue growth 150.1% a year over 10 years. Return on equity 30.8%.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.